Formulation Development White Papers & Articles

  1. Optimize Your High-Value Cell Lines 3/24/2025

    Discover high-throughput solutions designed to accelerate the selection of high-producing mammalian cell lines and how recombinant cell lines are projected to exceed $10 billion by 2030.

  2. mTOR Pathway 3/24/2025

    Explore the mTOR signaling pathway and reveal how mTORC1 regulates cell growth, metabolism, and survival to ensure cellular function and adaptation to environmental cues.

  3. VEGF Signaling Pathway 3/24/2025

    In Alzheimer's disease, reduced VEGF levels are linked to neurodegeneration, which can offer therapeutic potential. Discover how experimental treatments show promise in reducing memory impairment and beta-amyloid deposition.

  4. Neuroinflammation In Alzheimer's Disease Pathway 3/24/2025

    Recent research highlights neuroinflammation's role in AD progression, which suggests immune modulation as a potential therapeutic strategy. Learn more about neuroinflammatory processes in AD pathology.

  5. Alzheimer's Disease Pathway 3/24/2025

    Alzheimer’s disease (AD) affects 50 million people globally, causing cognitive decline. Explore the signaling pathways of amyloid beta and tau proteins, linking them to neuronal death and AD symptoms.

  6. Thunderstruck By Antibody-Drug Conjugates 3/18/2025

    Antibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.

  7. Driving Document Review Efficiency In CROs 3/14/2025

    Discover strategies to enhance document review efficiency in CROs, which includes modern approaches to streamline processes, reduce delays, and improve collaboration.

  8. Large Volume Autoinjector Design 3/13/2025

    Developing high-volume autoinjectors for concentrated drugs presents challenges in delivery, absorption, and patient usability raises concerns about their practicality and long-term effectiveness.

  9. Molecular Properties Of PROTACs And The Relationship To Formulation Design 3/4/2025

    Here, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.

  10. The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly 3/3/2025

    In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.